Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      EC Approves Bristol-Myers Squibb’s Sprycel in Combination with Chemotherapy for Treatment of Pediatric Patients

      FDA Approvals
      Bristol-Myers Squibb Co. announced that the EC has approved Sprycel in combination with chemotherapy for the treatment of pediatric patients with newly diagnosed Philadelphia...

      Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China

      Asia
      Samsung Bioepis Co., Ltd. announced its expansion in mainland China through a licensing agreement with C-Bridge Capital. The agreement covers multiple biosimilar candidates from...

      US FDA grants Breakthrough Therapy Designation for potential next-generation RSV medicine MEDI8897

      FDA Approvals
      AstraZeneca and its global biologics research and development arm, MedImmune, announced that the US FDA has granted Breakthrough Therapy Designation (BTD) for MEDI8897, an...

      Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

      Drug Development
      Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM announced a technology partnering and collaboration agreement. This agreement creates the...

      AstraZeneca collaborates with Aptamer Group on next-gen drug delivery devices

      Drug Development
      The two-year project will see Astrazeneca exploring the use of aptamer technology for targeted delivery of the kidney. Aptamers are emerging as promising therapeutic agents....

      Certara Launches Version 18 of Its Physiologically-based Pharmacokinetic Simcyp Simulator

      Drug Development
      Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, announced the launch of version 18 of its...

      Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx

      Drug Development
      The Janssen Pharmaceutical Companies of Johnson & Johnson announced a worldwide collaboration and license agreement with MeiraGTx Holdings plc, a clinical-stage gene therapy company,...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.